Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Elstein

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Israel Journal of Medical Sciences|November 1, 1994
Use of the APACHE II severity score in an Israeli GICUM Hersch, D Elstein, A Zimran
Acta Neurologica Scandinavica|March 23, 2007
Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?A Halperin, D Elstein, A Zimran
Clinical Genetics|October 27, 1998
Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher diseaseD Elstein, A Abrahamov, A Zimran
Bailliere'S Clinical Haematology|March 14, 1998
Skeletal involvement in Gaucher's diseaseD Elstein, M Itzchaki, H J Mankin
QJM : Monthly Journal of the Association of Physicians|January 2, 2003
Decreased salivary output in patients with Gaucher diseaseB Dayan, D Elstein, A Zimran, et al.
Blood Cells, Molecules & Diseases|December 17, 2002
Chitotriosidase deficiency in survivors of Candida sepsisM Masoud, B Rudensky, D Elstein, et al.
The Israel Medical Association Journal : IMAJ|September 29, 2001
How B12 deficiency can impact on the individual and how society can impact on B12 deficiencyY Gielchinsky, D Elstein, A Abrahamov, et al.
Blood Cells, Molecules & Diseases|October 29, 1998
Commentary: low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher diseaseD Elstein, A Abrahamov, M Itzchaki, et al.
American Journal of Human Genetics|October 20, 2001
Ethical guidelines for enzyme therapy in neuronopathic Gaucher diseaseD Elstein, A Steinberg, A Abrahamov, et al.
British Journal of Haematology|September 6, 2000
Withdrawal of enzyme replacement therapy in Gaucher's diseaseD Elstein, A Abrahamov, I Hadas-Halpern, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Israel Journal of Medical Sciences|November 1, 1994
Use of the APACHE II severity score in an Israeli GICUM Hersch, D Elstein, A Zimran
Acta Neurologica Scandinavica|March 23, 2007
Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?A Halperin, D Elstein, A Zimran
Clinical Genetics|October 27, 1998
Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher diseaseD Elstein, A Abrahamov, A Zimran
Bailliere'S Clinical Haematology|March 14, 1998
Skeletal involvement in Gaucher's diseaseD Elstein, M Itzchaki, H J Mankin
QJM : Monthly Journal of the Association of Physicians|January 2, 2003
Decreased salivary output in patients with Gaucher diseaseB Dayan, D Elstein, A Zimran, et al.
Blood Cells, Molecules & Diseases|December 17, 2002
Chitotriosidase deficiency in survivors of Candida sepsisM Masoud, B Rudensky, D Elstein, et al.
The Israel Medical Association Journal : IMAJ|September 29, 2001
How B12 deficiency can impact on the individual and how society can impact on B12 deficiencyY Gielchinsky, D Elstein, A Abrahamov, et al.
Blood Cells, Molecules & Diseases|October 29, 1998
Commentary: low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher diseaseD Elstein, A Abrahamov, M Itzchaki, et al.
American Journal of Human Genetics|October 20, 2001
Ethical guidelines for enzyme therapy in neuronopathic Gaucher diseaseD Elstein, A Steinberg, A Abrahamov, et al.
British Journal of Haematology|September 6, 2000
Withdrawal of enzyme replacement therapy in Gaucher's diseaseD Elstein, A Abrahamov, I Hadas-Halpern, et al.
Pageof 9